• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性特发性荨麻疹患者对口服环孢素治疗和高敏 C 反应蛋白水平的反应。

Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria.

机构信息

Department of Dermatology, Dokkyo Medical University Koshigaya Hospital, Koshigaya, Saitama, Japan.

出版信息

Int J Dermatol. 2010 May;49(5):579-84. doi: 10.1111/j.1365-4632.2010.04384.x.

DOI:10.1111/j.1365-4632.2010.04384.x
PMID:20534097
Abstract

BACKGROUND

Chronic idiopathic urticaria (CIU) is often resistant to common treatment of uriticaria.

OBJECTIVE

To find out clinical and laboratory findings affecting the response of oral cyclosporine therapy in CIU.

SUBJECTS AND METHODS

The response of oral cyclosporine therapy in 15 patients with CIU (male:female = 5:10, age 16-60 years old, mean 40.0 years old) was studied. Cyclosporine trough level was measured with an enzyme-multiplied immunoassay, and high sensitivity-CRP was measured with a nephelometric assay. The relation between high sensitivity-CRP level and clinical and laboratory findings in CIU was also studied.

RESULTS

All the 15 CIU patients responded to oral cyclosporine therapy. High sensitivity-CRP levels before the start of therapy were elevated in nine of 15 CIU patients. The distributions of treatment duration and basophile leukocytes counts in elevated high sensitivity-CRP patients (8.7 +/- 1.3 months, 0.20 +/- 0.05%) were significantly shorter and elevated than those in patients showing no elevation (22.7 +/- 1.7 months, 0.40 +/- 0.05%) (P < 0.05, P < 0.05), respectively. No other clinical and laboratory findings between patients with elevated and not elevated high sensitivity-CRP showed any significant differences.

CONCLUSION

Chronic idiopathic urticaria patients with elevated high sensitivity-CRP showed good response to oral cyclosporine therapy.

摘要

背景

慢性特发性荨麻疹(CIU)通常对荨麻疹的常规治疗有抗性。

目的

找出影响 CIU 口服环孢素治疗反应的临床和实验室发现。

受试者和方法

研究了 15 例 CIU 患者(男:女= 5:10,年龄 16-60 岁,平均 40.0 岁)口服环孢素治疗的反应。用酶联免疫吸附法测定环孢素谷浓度,用散射比浊法测定高敏-CRP。还研究了高敏-CRP 水平与 CIU 临床和实验室发现之间的关系。

结果

15 例 CIU 患者均对口服环孢素治疗有反应。15 例 CIU 患者中有 9 例在开始治疗前高敏-CRP 水平升高。高敏-CRP 升高患者的治疗持续时间和嗜碱性粒细胞计数分布(8.7 ± 1.3 个月,0.20 ± 0.05%)明显短于未升高患者(22.7 ± 1.7 个月,0.40 ± 0.05%)(P < 0.05,P < 0.05)。高敏-CRP 升高和未升高患者之间的其他临床和实验室发现无显著差异。

结论

高敏-CRP 升高的慢性特发性荨麻疹患者对口服环孢素治疗反应良好。

相似文献

1
Response to oral cyclosporine therapy and high sensitivity-CRP level in chronic idiopathic urticaria.慢性特发性荨麻疹患者对口服环孢素治疗和高敏 C 反应蛋白水平的反应。
Int J Dermatol. 2010 May;49(5):579-84. doi: 10.1111/j.1365-4632.2010.04384.x.
2
The correlation between response to oral cyclosporin therapy and systemic inflammation, metabolic abnormality in patients with psoriasis.银屑病患者口服环孢素治疗反应与全身炎症、代谢异常之间的相关性。
Arch Dermatol Res. 2008 Nov;300(10):545-50. doi: 10.1007/s00403-008-0887-5. Epub 2008 Sep 17.
3
Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.环孢素治疗慢性特发性荨麻疹:一项双盲、随机、安慰剂对照试验。
J Am Acad Dermatol. 2006 Oct;55(4):705-9. doi: 10.1016/j.jaad.2006.04.078.
4
Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation.低剂量和短期环孢素治疗慢性特发性荨麻疹患者:临床和免疫学评估
J Dermatol. 2008 May;35(5):276-82. doi: 10.1111/j.1346-8138.2008.00466.x.
5
A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria.回顾性分析慢性特发性荨麻疹患者的临床表现、甲状腺自身免疫、实验室特征及治疗方法。
Ann Allergy Asthma Immunol. 2009 Dec;103(6):496-501. doi: 10.1016/S1081-1206(10)60266-9.
6
[Extended cyclosporine-A--treatment for severe chronic urticaria].[环孢素A延长治疗重症慢性荨麻疹]
Harefuah. 2006 Jun;145(6):411-4, 471.
7
Effect of arterial hypertension on chronic urticaria duration.动脉高血压对慢性荨麻疹病程的影响。
Ann Allergy Asthma Immunol. 2009 Nov;103(5):407-10. doi: 10.1016/S1081-1206(10)60360-2.
8
Serum interleukin-6 level is reflected in elevated high-sensitivity C-reactive protein level in patients with systemic sclerosis.血清白细胞介素-6 水平反映了系统性硬化症患者高敏 C 反应蛋白水平的升高。
J Dermatol. 2010 Sep;37(9):801-6. doi: 10.1111/j.1346-8138.2010.00883.x.
9
Different effect of oral cyclosporine therapy and oral antihistamine therapy on serum high-sensitivity C-reactive protein level and thymus and activation-regulated chemokine level in atopic dermatitis in older children and adulthood.口服环孢素疗法与口服抗组胺药疗法对大龄儿童及成人特应性皮炎患者血清高敏C反应蛋白水平及胸腺和活化调节趋化因子水平的不同影响。
Int J Dermatol. 2015 Jun;54(6):648-55. doi: 10.1111/ijd.12374. Epub 2014 Oct 14.
10
Comparison of short- and long-term cyclosporine A therapy in chronic idiopathic urticaria.慢性特发性荨麻疹短期与长期环孢素A治疗的比较。
J Dermatolog Treat. 2004 Jun;15(3):164-8. doi: 10.1080/09546630410033006.

引用本文的文献

1
Role of Cyclosporine (CsA) in Immuno-dermatological Conditions.环孢素(CsA)在免疫性皮肤病中的作用。
Indian Dermatol Online J. 2022 Sep 5;13(5):585-599. doi: 10.4103/idoj.idoj_189_22. eCollection 2022 Sep-Oct.
2
Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?奥马珠单抗与环孢素 A 治疗慢性自发性荨麻疹:我们能否定义更好应答的表型?
An Bras Dermatol. 2022 Sep-Oct;97(5):592-600. doi: 10.1016/j.abd.2022.03.003. Epub 2022 Jul 16.
3
The challenges of chronic urticaria part 2: Pharmacological treatment, chronic inducible urticaria, urticaria in special situations.
慢性荨麻疹的挑战 第2部分:药物治疗、慢性诱导性荨麻疹、特殊情况下的荨麻疹
World Allergy Organ J. 2021 Jun 3;14(6):100546. doi: 10.1016/j.waojou.2021.100546. eCollection 2021 Jun.
4
The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria.韩国成人及儿童慢性自发性荨麻疹的KAAACI/KDA循证实践指南:第2部分。H1抗组胺药难治性慢性荨麻疹的管理。
Allergy Asthma Immunol Res. 2020 Sep;12(5):750-770. doi: 10.4168/aair.2020.12.5.750.
5
Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.慢性自发性荨麻疹中的生物标志物:当前靶点及临床意义
J Asthma Allergy. 2019 Sep 20;12:285-295. doi: 10.2147/JAA.S184986. eCollection 2019.
6
Factors Predicting the Response to Cyclosporin Treatment in Patients With Chronic Spontaneous Urticaria: A Systematic Review.慢性自发性荨麻疹患者对环孢素治疗反应的预测因素:一项系统评价
Allergy Asthma Immunol Res. 2019 Sep;11(5):736-755. doi: 10.4168/aair.2019.11.5.736.
7
Chronic Urticaria: An Overview of Treatment and Recent Patents.慢性荨麻疹:治疗概述与近期专利
Recent Pat Inflamm Allergy Drug Discov. 2019;13(1):27-37. doi: 10.2174/1872213X13666190328164931.
8
Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.慢性自发性荨麻疹:病因、诊断及治疗的最新进展
Ther Adv Chronic Dis. 2015 Nov;6(6):304-13. doi: 10.1177/2040622315603951.